SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042028
Filing Date
2019-11-08
Accepted
2019-11-08 08:23:10
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-10q_20190930.htm 10-Q 2309985
2 EX-31.1 ovid-ex311_6.htm EX-31.1 21251
3 EX-31.2 ovid-ex312_8.htm EX-31.2 21502
4 EX-32.1 ovid-ex321_7.htm EX-32.1 7559
5 GRAPHIC g2ffz4qp00ur000001.jpg GRAPHIC 34354
  Complete submission text file 0001564590-19-042028.txt   6407925

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovid-20190930.xml EX-101.INS 1151770
7 XBRL TAXONOMY EXTENSION SCHEMA ovid-20190930.xsd EX-101.SCH 43244
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovid-20190930_cal.xml EX-101.CAL 33844
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovid-20190930_def.xml EX-101.DEF 159932
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovid-20190930_lab.xml EX-101.LAB 347757
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovid-20190930_pre.xml EX-101.PRE 276096
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 191202184
SIC: 2834 Pharmaceutical Preparations